$10.07

-0.06 (-0.59%)

After Hours: $10.25 (+0.18, +1.84%)

Weekly Expected Move ±11.1%

$8 $9 $10 $11 $12

NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 31 · $423.9M mcap · 41M float · 0.849% daily turnover · Short 44% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$845M +4.1% ▲

5Y CAGR: +2.7%

Gross Profit

$290M +13.1% ▲

5Y CAGR: +8.8%

Operating Income

-$28M -186.6% ▼

Net Income

-$70M -47.4% ▼

EPS (Diluted)

$-1.70 -45.3% ▼

EBITDA

$4M -94.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$818M	$859M	$893M	$811M	$845M
YoY Growth	+10.8%	+5.0%	+4.0%	-9.2%	+4.1%
Cost of Revenue	$547M	$576M	$603M	$554M	$554M
Gross Profit	$272M	$284M	$290M	$257M	$290M
Gross Margin	33.2%	33.0%	32.5%	31.7%	34.4%
R&D Expenses	$72M	$77M	$85M	$87M	$91M
SG&A Expenses	$126M	$118M	$128M	$138M	$133M
Operating Expenses	$197M	$195M	$213M	$225M	$318M
Operating Income	$74M	$88M	$77M	$32M	-$28M
Operating Margin	9.1%	10.3%	8.6%	4.0%	-3.3%
Interest Expense	$43M	$41M	$29M	$31M	$36M
Income Before Tax	$29M	$44M	$31M	$5M	-$59M
Tax Expense	$11M	$14M	-$17M	$52M	$11M
Net Income	$17M	$30M	$48M	-$48M	-$70M
Net Margin	2.1%	3.5%	5.4%	-5.9%	-8.3%
EPS (Diluted)	$0.43	$0.73	$1.08	$-1.17	$-1.70
EBITDA	$104M	$114M	$95M	$63M	$4M
Shares Outstanding	40M	42M	50M	41M	41M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$209M	$206M	$200M	$213M	$203M	$229M	$210M	$216M
Cost of Revenue	$142M	$139M	$131M	$136M	$136M	$151M	$140M	$143M
Gross Profit	$67M	$67M	$68M	$77M	$68M	$78M	$70M	$73M
Gross Margin	32.0%	32.6%	34.3%	36.0%	33.3%	34.0%	33.3%	33.6%
R&D Expenses	$22M	$22M	$24M	$22M	$21M	$24M	$22M	$22M
SG&A Expenses	$36M	$34M	$34M	$33M	$33M	$34M	$33M	$36M
Operating Expenses	$58M	$56M	$57M	$55M	$148M	$58M	$54M	$58M
Operating Income	$9M	$11M	$11M	$22M	-$81M	$20M	$15M	$14M
Operating Margin	4.4%	5.3%	5.6%	10.4%	-39.8%	8.6%	7.3%	6.7%
Interest Expense	$8M	$8M	$8M	$10M	$9M	$8M	$8M	$17M
Income Before Tax	$800K	$2M	$2M	$11M	-$87M	$14M	$4M	-$6M
Tax Expense	-$700K	$52M	$3M	$4M	$2M	$2M	$1M	$2M
Net Income	$1M	-$50M	-$300K	$7M	-$89M	$12M	$2M	-$8M
Net Margin	0.7%	-24.3%	-0.2%	3.2%	-43.9%	5.3%	1.1%	-3.8%
EPS (Diluted)	$0.03	$-1.23	$-0.01	$0.13	$-2.15	$0.29	$0.05	$-0.19
EBITDA	$14M	$17M	$18M	$28M	-$71M	$29M	$22M	$21M
Shares Outstanding	41M	41M	41M	51M	42M	42M	42M	42M

VREX NASDAQ